The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2020 | Real-world management of patients with AL amyloidosis
Efstathios Kastritis
• 16 Jun 2020
Efstathios Kastritis, MD, of the University of Athens School of Medicine, Athens, Greece, discusses the real-world management of patients with systemic light-chain (AL) amyloidosis based on evidence presented in the ANDROMEDA study (NCT03201965). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
